TradeWorx’s Array Biopharma Inc ARRY Stock Holding History

TradeWorx’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-13,480	Closed	-$68K	–	605
2013 Q4	$68K	Buy	+13,480	New	+$73.4K	0.03%	461

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TradeWorx's ARRY Position: Q1 2014 in Review

TradeWorx sold out of Array Biopharma Inc (ARRY) in Q1 2014, closing a stake of 13,480 shares — an estimated $68K sold.

TradeWorx first reported a position in ARRY in Q4 2013 and held it in 1 quarter. The position peaked at $68K in Q4 2013. 122 funds tracked by Wall St. Rank hold ARRY as of Q1 2014.

TradeWorx reported no remaining Array Biopharma Inc position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 13,480 Array Biopharma Inc shares in Q1 2014, an estimated $68K.
TradeWorx first reported a position in Array Biopharma Inc in Q4 2013 and held it in 1 quarter.
TradeWorx's Array Biopharma Inc position peaked at $68K in Q4 2013.
122 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.